Pregnancy Study
The pregnancy study investigates how best to use your asthma medication during pregnancy and what impact this has on your baby’s health.
This study is not currently recruiting.
Who is the study for?
Women between 12 and 22 weeks of pregnancy who have a diagnosis of asthma, use regular asthma medication and are over 18 years of age.
What appointments will I need to attend?
You will attend an initial study visit and up to 6 monthly visits during your pregnancy.
What's involved in the study?
During your pregnancy we will:
Ask about asthma medication, perform some breathing tests and collect samples such as blood at your initial visit. We provide education on how to manage your asthma and use medications then assign participants at random to one of the following management groups:
Group 1: The Asthma Assessment Group
Participants assigned to this study group will only attend one study visit.
Group 2: The FeNO Management Group
Participants assigned to this group are asked to attend 5-6 monthly visits during their pregnancy, asthma medications may be adjusted according to the results of a breathing test every 2 months. Preventer medication may be changed at the first visit.
After your baby is born we will:
Collect a sample of cord blood from the placenta. Your child may then be invited to participate in the following:
-
BLT Nutritional Assessment Visits at 2 and 3 years of age
Medical Records
We would like to
-
Access your medical records from John Hunter Hospital and/or details of the birth from the hospital’s Obstetric Database. The information we obtain about you and your baby is routinely collected at antenatal visits and during the birth.
-
Access your child’s medical records to obtain information about hospitalisations during the first year of life.